Insulin Resistance

What Insulin Resistance Is

Insulin's normal job is to tell cells in muscle and fat tissue to pull glucose out of the blood and use or store it, largely by moving a glucose transporter called GLUT4 to the cell surface.^[2] In insulin resistance, that signal doesn't land the way it should. Target tissues respond less to a given amount of insulin, and the pancreas compensates by releasing more insulin to hold blood sugar steady.^[1]

There's no single lab test that defines insulin resistance the way a strep culture defines strep. Research recognizes it indirectly, through the metabolic patterns it produces, rather than through one clinical marker on its own.^[1] The closest thing to a gold standard, the hyperinsulinemic-euglycemic clamp, is a multi-hour infusion procedure used almost exclusively in research. Outside research, scientists lean on surrogate measures built from more accessible values, most often a fasting glucose and fasting insulin drawn from the same blood sample.^[1]

Insulin resistance shows up across a range of conditions researchers group loosely as its disease spectrum, including type 2 diabetes, cardiovascular disease, nonalcoholic fatty liver disease, metabolic syndrome, and PCOS.^[1] The PCOS link is one of the most studied in that group. What the Research Shows below covers what the current evidence says about how the two relate.

Why People Track Metrics Tied to Insulin Resistance

Because there's no stand-alone insulin-resistance test, people interested in their own metabolic health typically track a small cluster of lab values instead of one number. Fasting insulin and fasting glucose are the most common pair, drawn together and combined into HOMA-IR, a research index scientists use to estimate insulin sensitivity across groups in population studies.^[5] HbA1c adds a longer view, reflecting average glucose over roughly the prior three months rather than one morning's value, and blood glucose readings from a fingerstick or continuous glucose monitor fill in the day-to-day pattern between lab draws. C-peptide shows up in some research workups as a marker of how much insulin the pancreas is producing on its own. For how these labs come up in PCOS specifically, see the PCOS entry.

How Go Go Gaia Supports Tracking It

Upload a lab report and Go Go Gaia reads fasting insulin, fasting glucose, HbA1c, and C-peptide values into your record, storing each in its standard unit and charting it over time. Those lab points sit on the same timeline as CGM data from Dexcom, Libre, or Ultrahuman, plus your cycle phase and other labs, so a once- or twice-a-year lab draw and day-to-day glucose data live in one place. The app displays your results. It doesn't calculate HOMA-IR, interpret your labs, or offer any diabetes-related guidance.

What the Research Shows

A 2022 review in the World Journal of Diabetes put the prevalence of insulin resistance among women with PCOS at 35% to 80% across published studies, describing it as independent of BMI and body fat distribution.^[4]

Insulin sensitivity also isn't flat across the menstrual cycle. The BioCycle Study followed 257 healthy premenopausal women across multiple points in a cycle and found insulin-resistance measures shifted between the midfollicular and early luteal phases, with both estradiol and progesterone positively associated with the change.^[6] The insulin entry covers that study's numbers in full.

A comprehensive 2012 review in Endocrine Reviews described insulin resistance in PCOS as intrinsic to the condition, present in lean as well as higher-weight women, rather than solely a consequence of excess weight.^[3]

Related Terms

Frequently Asked Questions

Educational information based on published sources. Not medical advice. For personal concerns, please consult your doctor.

What is insulin resistance?

Insulin resistance is a physiological state in which cells in the liver, muscle, and fat tissue respond less to insulin's signal to take up glucose from the blood, so the body needs more insulin to hold blood sugar steady. It isn't a stand-alone diagnosis. Researchers recognize it through the metabolic conditions it's linked to, including type 2 diabetes, metabolic syndrome, and PCOS.^[1]

Is insulin resistance the same thing as diabetes?

No. Insulin resistance is a physiological state that can occur alongside several different conditions, including type 2 diabetes, cardiovascular disease, nonalcoholic fatty liver disease, metabolic syndrome, and PCOS. Having insulin resistance doesn't mean someone has, or will develop, any one of those conditions. There's no single test that defines it on its own, so researchers describe it through a pattern of related findings rather than one clinical marker.^[1]

How is insulin resistance connected to PCOS?

Research describes insulin resistance as one of the most studied features of PCOS. A 2022 review put its prevalence among women with PCOS at 35% to 80% across published studies, describing it as present independent of body mass index and body fat distribution.^[4] Earlier research has treated it as intrinsic to PCOS rather than a downstream effect of body weight alone.^[3]